COVID-19 pandemic is still sweeping through the world impacting the global economy in significant ways. However, many countries have been able to start economic activities by adopting the testing, tracking, and tracing (TTT) strategy. Due to the emphasis on testing, the global demand for COVID-19 testing is expected to go further up in the coming months. Diagnostic companies are at the forefront in assisting governments to meet the rising demand for testing in their countries. Several in vitro diagnostic (IVD) companies based in the Asia Pacific (APAC) region have emerged as key suppliers of COVID-19 testing.
In Malaysia, the government relied on stringent movement control restrictions (MCO) during the initial stages of the pandemic as the country was trying to meet the rising demand for COVID-19 tests. The diagnostics and life sciences companies in the country rose to the challenge and assisted the government by developing the required reagents as well as tests. Currently, many of these companies have expanded beyond the borders of Malaysia by exporting their COVID-19 tests and to international markets.
Dr. Syamala Ariyanchinra, Research Director of AcuBiz Consulting talked with Mr. Law Eng Lim, founder and CEO of Reszon Diagnostics about the emerging market trends in various countries for COVID-19 testing and how the company plans to navigate through this uncertain terrain.